Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Vaccines
Pharma
Vaxxas raises $23M to fund needle-free COVID-19 vaccine trial
Vaxxas has secured funding to support clinical development of its needle-free COVID-19 vaccine, stuffing its coffers with $23 million from investors.
Nick Paul Taylor
Dec 6, 2022 10:25am
LTS Lohmann leads investment in needle-free delivery specialist
Nov 29, 2022 10:53am
Moderna pads the case for its bivalent COVID-19 booster
Nov 14, 2022 12:13pm
Novartis sells Singapore plant to BioNTech for vax production
Nov 14, 2022 10:15am
Healthcare Twitter influencers beam over Pfizer's RSV shot data
Nov 4, 2022 10:15am
Pfizer, GSK prep for battle in the world's first RSV vax market
Nov 3, 2022 9:50am
